FAST NEWS: WuXi AppTec Sees Profit Doubling in First Three Quarters
The latest: Pharmaceutical services outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) on Thursday estimated its revenue in the first three quarters of this year rose 71.87% to 28.4 billion…
RELATED ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
BRIEF: WuXi AppTec sells advanced therapies units in U.K. and U.S.
2359.HK 603259.SHG
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
BRIEF: Carote’s revenue jumps sharply in first three quarters
2549.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG
Discover hidden China stock gems in our weekly newsletter